![Mahima Datla](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Mahima Datla
Sociétés | Poste | Début | Fin |
---|---|---|---|
Biological E. Ltd.
![]() Biological E. Ltd. Pharmaceuticals: MajorHealth Technology Biological E. Ltd. operates as a biological products company. It manufactures liver extracts and anti-coagulants. The company was founded by Datla Venkata Krishnam Raju in 1953 and is headquartered in Hyderabad, India. | Directeur/Membre du Conseil | 04/10/2013 | - |
Directeur Général | - | - | |
Global Health Innovative Technology Fund
![]() Global Health Innovative Technology Fund Investment ManagersFinance Global Health Innovative Technology Fund provides funding of scientific research and development for anti-infectives and diagnostics for diseases that affect the developing world. Its activities include facilitation of global research and development partnerships for the discovery and development of new health technologies for the developing world, investment in these global research and development partnerships through a grant-making mechanism and advancement of Japan’s contribution to global health. The company is headquartered in Minato-ku, Japan. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Mahima Datla
Statistiques
Internationale
Inde | 2 |
Japon | 2 |
Opérationnelle
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Sectorielle
Health Technology | 2 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Biological E. Ltd.
![]() Biological E. Ltd. Pharmaceuticals: MajorHealth Technology Biological E. Ltd. operates as a biological products company. It manufactures liver extracts and anti-coagulants. The company was founded by Datla Venkata Krishnam Raju in 1953 and is headquartered in Hyderabad, India. | Health Technology |
Global Health Innovative Technology Fund
![]() Global Health Innovative Technology Fund Investment ManagersFinance Global Health Innovative Technology Fund provides funding of scientific research and development for anti-infectives and diagnostics for diseases that affect the developing world. Its activities include facilitation of global research and development partnerships for the discovery and development of new health technologies for the developing world, investment in these global research and development partnerships through a grant-making mechanism and advancement of Japan’s contribution to global health. The company is headquartered in Minato-ku, Japan. | Finance |
- Bourse
- Insiders
- Mahima Datla
- Expérience